Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

176
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
176
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

289
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
289
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

309
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
309
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

568
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
568
Multiple Regression01:25

Multiple Regression

3.2K
Multiple regression assesses a linear relationship between one response or dependent variable and two or more independent variables. It has many practical applications.
Farmers can use multiple regression to determine the crop yield based on more than one factor, such as water availability, fertilizer, soil properties, etc. Here, the crop yield is the response or dependent variable as it depends on the other independent variables. The analysis requires the construction of a scatter plot...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Powering RCTs for Marginal Effects With GLMs Using Prognostic Score Adjustment.

Statistics in medicine·2026
Same author

"Within-Trial" Prognostic Score Adjustment Is Targeted Maximum Likelihood Estimation.

Pharmaceutical statistics·2026
Same author

Effect of Adherence to Oral Semaglutide on Glycemic Control in People With Type 2 Diabetes Treated With Metformin: Protocol for an Open-Label Clinical Trial.

JMIR research protocols·2025
Same author

Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based study.

British journal of haematology·2025
Same author

Growth Response to Weekly Somapacitan Therapy in Children With GH Deficiency Is Related to GH Thresholds in GH Stimulation Testing.

Journal of the Endocrine Society·2025
Same author

Composite likelihood inference for space-time point processes.

Biometrics·2025
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Sep 13, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

A Tutorial on Improving RCT Power Using Prognostic Score Adjustment for Linear Models.

Emilie Højbjerre-Frandsen1,2, Mathias Lerbech Jeppesen1, Rasmus Kuhr Jensen1

  • 1Biostatistics, Novo Nordisk A/S, Søborg, Denmark.

Pharmaceutical Statistics
|July 31, 2025
PubMed
Summary
This summary is machine-generated.

Leveraging historical data with linear prognostic score adjustment can boost clinical trial power. This method improves treatment effect estimation and maintains type I error control, outperforming traditional techniques.

Keywords:
causal inferencediabeteshistorical dataprognostic scorerandomized trials

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Related Experiment Videos

Last Updated: Sep 13, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmacometrics

Background:

  • Historical data utilization in clinical trials is a long-standing area of research.
  • Recent advancements focus on linear adjustment for prognostic scores to enhance statistical power.
  • Asymptotic and finite sample optimality results support these advanced estimation techniques.

Purpose of the Study:

  • To review and provide guidelines for linear adjustment using prognostic scores in clinical trials.
  • To evaluate the performance of this method against standard approaches like propensity score matching and ANCOVA.
  • To demonstrate the practical application and benefits in a real-world clinical trial setting.

Main Methods:

  • Review of plug-in and linear estimators for average treatment effect in randomized controlled trials (RCTs).
  • Development of guidelines for historical data curation and prognostic score construction.
  • Simulation studies comparing linear adjustment with propensity score matching for RCTs (PSM-RCT) and ANCOVA.
  • Case study application in a phase IIIb clinical trial for type 2 diabetes.

Main Results:

  • Linear adjustment for prognostic scores avoids biased treatment effect estimates and controls type I error, unlike PSM-RCT.
  • The method demonstrates robustness against assumption deviations and prognostic model performance issues.
  • A case study confirmed increased prospective power in a type 2 diabetes trial.

Conclusions:

  • Linear adjustment for prognostic scores is an effective method to increase power in clinical trials.
  • The approach offers advantages over traditional methods, particularly in maintaining estimate validity and error control.
  • Recommendations are provided for implementation, with considerations for limitations such as subgroup analyses.